Loading...

Mark Fuster

TitleProfessor In Residence
InstitutionUniversity of California San Diego
DepartmentMedicine
Address9500 Gilman Drive #9111-J
La Jolla CA 92093
Phone858-552-8585
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Dendritic Cell Proteoglycans and Reprogramming Cancer Immunity
    VA I01BX003688Oct 1, 2017 - Sep 30, 2021
    Role: Principal Investigator
    Lymphatic Microenvironment: Altering Cell Traffic by Targeting Glycans
    NIH/NHLBI R01HL107652Jul 15, 2012 - May 31, 2016
    Role: Principal Investigator
    Glycosaminoglycans and Cell Traffic in the Lymphatic Microenvironment
    VA I01BX000987Apr 1, 2011 - Mar 31, 2014
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Ha D, Ries AL, Mazzone PJ, Lippman SM, Fuster M. Exercise capacity and cancer-specific quality of life following curative intent treatment of stage I-IIIA lung cancer. Support Care Cancer. 2018 Feb 10. PMID: 29429006.
      View in: PubMed
    2. Hepokoski M, Englert JA, Baron RM, Crotty-Alexander LE, Fuster M, Beitler JR, Malhotra A, Singh P. Ventilator-induced lung injury increases expression of endothelial inflammatory mediators in the kidney. Am J Physiol Renal Physiol. 2017 Apr 01; 312(4):F654-F660. PMID: 28365585.
      View in: PubMed
    3. Li J, Fuster M. Advances in lung cancer with a focus on ATS 2016 updates. J Thorac Dis. 2016 Jul; 8(Suppl 7):S566-8. PMID: 27606096; PMCID: PMC4990685.
    4. Johns SC, Yin X, Jeltsch M, Bishop JR, Schuksz M, El Ghazal R, Wilcox-Adelman SA, Alitalo K, Fuster M. Functional Importance of a Proteoglycan Coreceptor in Pathologic Lymphangiogenesis. Circ Res. 2016 Jul 08; 119(2):210-21. PMID: 27225479; PMCID: PMC4938725 [Available on 07/08/17].
    5. Ha D, Mazzone PJ, Ries AL, Malhotra A, Fuster M. The Utility of Exercise Testing in Patients with Lung Cancer. J Thorac Oncol. 2016 09; 11(9):1397-410. PMID: 27156441.
      View in: PubMed
    6. El Ghazal R, Yin X, Johns SC, Swanson L, Macal M, Ghosh P, Zuniga EI, Fuster M. Glycan Sulfation Modulates Dendritic Cell Biology and Tumor Growth. Neoplasia. 2016 05; 18(5):294-306. PMID: 27237321; PMCID: PMC4887599.
    7. Dyer DP, Salanga CL, Johns SC, Valdambrini E, Fuster M, Milner CM, Day AJ, Handel TM. The Anti-inflammatory Protein TSG-6 Regulates Chemokine Function by Inhibiting Chemokine/Glycosaminoglycan Interactions. J Biol Chem. 2016 Jun 10; 291(24):12627-40. PMID: 27044744; PMCID: PMC4933465.
    8. Block KI, Gyllenhaal C, Lowe L, Amedei A, Amin ARMR, Amin A, Aquilano K, Arbiser J, Arreola A, Arzumanyan A, Ashraf SS, Azmi AS, Benencia F, Bhakta D, Bilsland A, Bishayee A, Blain SW, Block PB, Boosani CS, Carey TE, Carnero A, Carotenuto M, Casey SC, Chakrabarti M, Chaturvedi R, Chen GZ, Chen H, Chen S, Chen YC, Choi BK, Ciriolo MR, Coley HM, Collins AR, Connell M, Crawford S, Curran CS, Dabrosin C, Damia G, Dasgupta S, DeBerardinis RJ, Decker WK, Dhawan P, Diehl AME, Dong JT, Dou QP, Drew JE, Elkord E, El-Rayes B, Feitelson MA, Felsher DW, Ferguson LR, Fimognari C, Firestone GL, Frezza C, Fujii H, Fuster M, Generali D, Georgakilas AG, Gieseler F, Gilbertson M, Green MF, Grue B, Guha G, Halicka D, Helferich WG, Heneberg P, Hentosh P, Hirschey MD, Hofseth LJ, Holcombe RF, Honoki K, Hsu HY, Huang GS, Jensen LD, Jiang WG, Jones LW, Karpowicz PA, Keith WN, Kerkar SP, Khan GN, Khatami M, Ko YH, Kucuk O, Kulathinal RJ, Kumar NB, Kwon BS, Le A, Lea MA, Lee HY, Lichtor T, Lin LT, Locasale JW, Lokeshwar BL, Longo VD, Lyssiotis CA, MacKenzie KL, Malhotra M, Marino M, Martinez-Chantar ML, Matheu A, Maxwell C, McDonnell E, Meeker AK, Mehrmohamadi M, Mehta K, Michelotti GA, Mohammad RM, Mohammed SI, Morre DJ, Muralidhar V, Muqbil I, Murphy MP, Nagaraju GP, Nahta R, Niccolai E, Nowsheen S, Panis C, Pantano F, Parslow VR, Pawelec G, Pedersen PL, Poore B, Poudyal D, Prakash S, Prince M, Raffaghello L, Rathmell JC, Rathmell WK, Ray SK, Reichrath J, Rezazadeh S, Ribatti D, Ricciardiello L, Robey RB, Rodier F, Rupasinghe HPV, Russo GL, Ryan EP, Samadi AK, Sanchez-Garcia I, Sanders AJ, Santini D, Sarkar M, Sasada T, Saxena NK, Shackelford RE, Shantha Kumara HMC, Sharma D, Shin DM, Sidransky D, Siegelin MD, Signori E, Singh N, Sivanand S, Sliva D, Smythe C, Spagnuolo C, Stafforini DM, Stagg J, Subbarayan PR, Sundin T, Talib WH, Thompson SK, Tran PT, Ungefroren H, Vander Heiden MG, Venkateswaran V, Vinay DS, Vlachostergios PJ, Wang Z, Wellen KE, Whelan RL, Yang ES, Yang H, Yang X, Yaswen P, Yedjou C, Yin X, Zhu J, Zollo M. Designing a broad-spectrum integrative approach for cancer prevention and treatment. Semin Cancer Biol. 2015 Dec; 35 Suppl:S276-S304. PMID: 26590477; PMCID: PMC4819002 [Available on 12/01/16].
    9. Yin X, Johns SC, El Ghazal R, Salanga CL, Handel TM, Fuster M. Examining Roles of Glycans in Chemokine-Mediated Dendritic-Endothelial Cell Interactions. Methods Enzymol. 2016; 570:335-55. PMID: 26921954.
      View in: PubMed
    10. Ha D, Fuster M, Ries AL, Wagner PD, Mazzone PJ. Heart Rate Recovery as a Preoperative Test of Perioperative Complication Risk. Ann Thorac Surg. 2015 Nov; 100(5):1954-62. PMID: 26410158.
      View in: PubMed
    11. Crotty Alexander L, Fuster M, Montgrain P, Malhotra A. The Need for More E-Cigarette Data: A Call to Action. Am J Respir Crit Care Med. 2015 Aug 01; 192(3):275-6. PMID: 26230232.
      View in: PubMed
    12. Wang Z, Dabrosin C, Yin X, Fuster M, Arreola A, Rathmell WK, Generali D, Nagaraju GP, El-Rayes B, Ribatti D, Chen YC, Honoki K, Fujii H, Georgakilas AG, Nowsheen S, Amedei A, Niccolai E, Amin A, Ashraf SS, Helferich B, Yang X, Guha G, Bhakta D, Ciriolo MR, Aquilano K, Chen S, Halicka D, Mohammed SI, Azmi AS, Bilsland A, Keith WN, Jensen LD. Broad targeting of angiogenesis for cancer prevention and therapy. Semin Cancer Biol. 2015 Dec; 35 Suppl:S224-S243. PMID: 25600295; PMCID: PMC4737670.
    13. Yin X, Johns SC, Kim D, Mikulski Z, Salanga CL, Handel TM, Macal M, Zúñiga EI, Fuster M. Lymphatic specific disruption in the fine structure of heparan sulfate inhibits dendritic cell traffic and functional T cell responses in the lymph node. J Immunol. 2014 Mar 01; 192(5):2133-42. PMID: 24493818; PMCID: PMC3960083.
    14. Kawamura T, Stephens B, Qin L, Yin X, Dores MR, Smith TH, Grimsey N, Abagyan R, Trejo J, Kufareva I, Fuster M, Salanga CL, Handel TM. A general method for site specific fluorescent labeling of recombinant chemokines. PLoS One. 2014; 9(1):e81454. PMID: 24489642; PMCID: PMC3904831.
    15. Haidar YM, Rahn DA, Nath S, Song W, Bazhenova L, Makani S, Fuster M, Sandhu AP. Comparison of outcomes following stereotactic body radiotherapy for non-small cell lung cancer in patients with and without pathological confirmation. Ther Adv Respir Dis. 2014 Feb; 8(1):3-12. PMID: 24334338.
      View in: PubMed
    16. Sandhu AP, Lau SK, Rahn D, Nath SK, Kim D, Song WY, Gulaya S, Fuster M, Bazhenova L, Mundt AJ. Stereotactic body radiation therapy in octogenarians with stage I lung cancer. Clin Lung Cancer. 2014 Mar; 15(2):131-5. PMID: 24157245.
      View in: PubMed
    17. Kim D, Fuster M, Nath SK, Bharne A, Read W, Bazhenova L, Song WY, Mundt AJ, Sandhu AP. Clinical outcomes following image-guided stereotactic body radiation for pulmonary oligometastases. J Radiosurg SBRT. 2012; 2(1):63-72. PMID: 29296343.
      View in: PubMed
    18. Kim D, Fuster M, Nath SK, Bharne A, Read W, Bazhenova L, Song WY, Mundt AJ, Sandhu AP. Clinical outcomes following image-guided stereotactic body radiation for pulmonary oligometastases. J Radiosurg SBRT. 2012; 1(4):317-325. PMID: 29296332.
      View in: PubMed
    19. Ahmad E, Sandhu AP, Fuster M, Messer K, Pu M, Nobiensky P, Bazhenova L, Seagren S. Hypofractionated radiotherapy as definitive treatment of stage I non-small cell lung cancer in older patients. Am J Clin Oncol. 2011 Jun; 34(3):254-8. PMID: 20562588.
      View in: PubMed
    20. Nath SK, Sandhu AP, Jensen L, Kim D, Bharne A, Nobiensky PD, Lawson JD, Fuster M, Bazhenova L, Song WY, Mundt AJ. Frameless image-guided stereotactic body radiation therapy for lung tumors with 4-dimensional computed tomography or 4-dimensional positron emission tomography/ computed tomography. Clin Lung Cancer. 2011 May; 12(3):180-6. PMID: 21663861.
      View in: PubMed
    21. Nath SK, Sandhu AP, Kim D, Bharne A, Nobiensky PD, Lawson JD, Fuster M, Bazhenova L, Song WY, Mundt AJ. Locoregional and distant failure following image-guided stereotactic body radiation for early-stage primary lung cancer. Radiother Oncol. 2011 Apr; 99(1):12-7. PMID: 21429608.
      View in: PubMed
    22. Yin X, Johns SC, Lawrence R, Xu D, Reddi K, Bishop JR, Varner JA, Fuster M. Lymphatic endothelial heparan sulfate deficiency results in altered growth responses to vascular endothelial growth factor-C (VEGF-C). J Biol Chem. 2011 Apr 29; 286(17):14952-62. PMID: 21343305; PMCID: PMC3083229.
    23. Yin X, Truty J, Lawrence R, Johns SC, Srinivasan RS, Handel TM, Fuster M. A critical role for lymphatic endothelial heparan sulfate in lymph node metastasis. Mol Cancer. 2010 Dec 20; 9:316. PMID: 21172016; PMCID: PMC3019167.
    24. Xu D, Fuster M, Lawrence R, Esko JD. Heparan sulfate regulates VEGF165- and VEGF121-mediated vascular hyperpermeability. J Biol Chem. 2011 Jan 07; 286(1):737-45. PMID: 20974861; PMCID: PMC3013032.
    25. Fuster M, Wang L. Endothelial heparan sulfate in angiogenesis. Prog Mol Biol Transl Sci. 2010; 93:179-212. PMID: 20807646; PMCID: PMC3703633.
    26. Sandhu AP, Messer K, Fuster M, Ahmad E, Pu M, Bazhenova L, Rose M, Seagren S. Definitive radiation therapy for stage I non-small-cell lung carcinoma: institutional experience with contemporary conformal planning. Clin Lung Cancer. 2009 Nov; 10(6):433-7. PMID: 19900862.
      View in: PubMed
    27. Zuberi RI, Ge XN, Jiang S, Bahaie NS, Kang BN, Hosseinkhani RM, Frenzel EM, Fuster M, Esko JD, Rao SP, Sriramarao P. Deficiency of endothelial heparan sulfates attenuates allergic airway inflammation. J Immunol. 2009 Sep 15; 183(6):3971-9. PMID: 19710461; PMCID: PMC2872128.
    28. Schuksz M, Fuster M, Brown JR, Crawford BE, Ditto DP, Lawrence R, Glass CA, Wang L, Tor Y, Esko JD. Surfen, a small molecule antagonist of heparan sulfate. Proc Natl Acad Sci U S A. 2008 Sep 02; 105(35):13075-80. PMID: 18725627.
      View in: PubMed
    29. Fuster M, Wang L, Castagnola J, Sikora L, Reddi K, Lee PH, Radek KA, Schuksz M, Bishop JR, Gallo RL, Sriramarao P, Esko JD. Genetic alteration of endothelial heparan sulfate selectively inhibits tumor angiogenesis. J Cell Biol. 2007 May 07; 177(3):539-49. PMID: 17470635; PMCID: PMC2064806.
    30. Garmy-Susini B, Makale M, Fuster M, Varner JA. Methods to study lymphatic vessel integrins. Methods Enzymol. 2007; 426:415-38. PMID: 17697894.
      View in: PubMed
    31. Brown JR, Fuster M, Li R, Varki N, Glass CA, Esko JD. A disaccharide-based inhibitor of glycosylation attenuates metastatic tumor cell dissemination. Clin Cancer Res. 2006 May 01; 12(9):2894-901. PMID: 16675586.
      View in: PubMed
    32. Wang L, Fuster M, Sriramarao P, Esko JD. Endothelial heparan sulfate deficiency impairs L-selectin- and chemokine-mediated neutrophil trafficking during inflammatory responses. Nat Immunol. 2005 Sep; 6(9):902-10. PMID: 16056228.
      View in: PubMed
    33. Fuster M, Esko JD. The sweet and sour of cancer: glycans as novel therapeutic targets. Nat Rev Cancer. 2005 Jul; 5(7):526-42. PMID: 16069816.
      View in: PubMed
    34. Fuster M, Brown JR, Wang L, Esko JD. A disaccharide precursor of sialyl Lewis X inhibits metastatic potential of tumor cells. Cancer Res. 2003 Jun 01; 63(11):2775-81. PMID: 12782582.
      View in: PubMed
    35. Brown JR, Fuster M, Whisenant T, Esko JD. Expression patterns of alpha 2,3-sialyltransferases and alpha 1,3-fucosyltransferases determine the mode of sialyl Lewis X inhibition by disaccharide decoys. J Biol Chem. 2003 Jun 27; 278(26):23352-9. PMID: 12686549.
      View in: PubMed
    36. Belting M, Borsig L, Fuster M, Brown JR, Persson L, Fransson LA, Esko JD. Tumor attenuation by combined heparan sulfate and polyamine depletion. Proc Natl Acad Sci U S A. 2002 Jan 08; 99(1):371-6. PMID: 11752393; PMCID: PMC117567.